市场趋势
| 短期 | 中期 | ||
| 行业 | Biotechnology (US) | 看涨 | 混合的 |
| Biotechnology (全球的) | 看涨 | 混合的 | |
| 股票 | Rezolute, Inc. | 看涨 | 看涨 |
AIStockmoo 评分
-0.3
| 分析师共识 | 4.0 |
| 内部交易活动 | NA |
| 价格波动 | -4.5 |
| 技术平均移动指标 | 0.0 |
| 技术振荡指标 | -0.5 |
| 平均 | -0.25 |
|
Rezolute Inc is a biopharmaceutical company. The company develops novel, sustained-release injectable therapies. It applies proprietary formulation and manufacturing capabilities to known, well-characterized molecules to create differentiated, patent-protected therapies that have the potential to significantly improve existing standards of care. Its pipeline products include RZ358 and RZ402. |
|
| 部门 | Healthcare |
| 行业 | Biotechnology |
| 投资方式 | Small Value |
| 内部持股比例 | 9.65% |
| 机构持股比例 | 52.00% |
所有权
| 姓名 | 日期 | 持有股份 |
|---|---|---|
| Caxton Corp | 30 Sep 2025 | 1,986,818 |
| 52周波幅 | ||
| 目标价格波幅 | ||
| 高 | 20.00 (Maxim Group, 109.21%) | 购买 |
| 中 | 17.00 (77.82%) | |
| 低 | 15.00 (Guggenheim, 56.90%) | 购买 |
| 平均值 | 17.25 (80.44%) | |
| 总计 | 4 购买 | |
| 平均价格@调整类型 | 8.76 | |
| 公司 | 日期 | 目标价格 | 调整类型 | 价格@调整类型 |
|---|---|---|---|---|
| BTIG | 20 Nov 2025 | 17.00 (77.82%) | 购买 | 9.65 |
| 18 Sep 2025 | 17.00 (77.82%) | 购买 | 8.20 | |
| Citizens | 29 Oct 2025 | 17.00 (77.82%) | 购买 | 9.53 |
| Guggenheim | 22 Sep 2025 | 15.00 (56.90%) | 购买 | 8.14 |
| Maxim Group | 19 Sep 2025 | 20.00 (109.21%) | 购买 | 7.70 |
该时间范围内无数据。
支撑、阻力和趋势线水平是由人工智能（AI）模型生成的，请谨慎解读。
投资组合